Michael H. Chapman - Concepedia

Author

Michael H. Chapman

Also Known As

M Chapman, M H Chapman, M. Chapman, M. H. Chapman, M.H. Chapman, Michael Chapman, Michael H Chapman, Michael H. Chapman, Michael Huw Chapman

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University College London University College London Hospitals NHS Foundation Trust University College Hospital The Royal Free Hospital Middlesex Hospital

About

Michael H. Chapman is an author at University College London specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	1.4K
2	Health Sciences	3	3	400
3	Engineering	1	1	46
4	Nursing	1	1	26
5	Allergy	1	1	206

Michael H. Chapman

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines Gideon M. Hirschfield, Jessica Dyson, Graeme Alexander, Gut Management GuidelinesImmunologyGastroenterologyPathologyPrimary Biliary Cirrhosis	2018	327
125I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography David Negus, Donald Pinto, L P Le Quesne, British journal of surgery PathologySurgeryThrombosisVenous ThrombosisVenous Disease Treatment	1968	310
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis Michael H. Chapman, Douglas Thorburn, Gideon M. Hirschfield, Gut Uk-psc GuidelinesDiagnosisPathologyGastroenterologySurgery	2019	272
Presentation and Management of Post-treatment Relapse in Autoimmune Pancreatitis/Immunoglobulin G4-Associated Cholangitis Neomal S. Sandanayake, Nicholas I. Church, Michael H. Chapman, Clinical Gastroenterology and Hepatology Autoimmune DiseaseAllergyImmunologyGastroenterologyPost-treatment Relapse	2009	206
Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis Michael H. Chapman, George Webster, Selina Bannoo, European Journal of Gastroenterology & Hepatology	2012	200
Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience J. Garland, John Buscombe, C. Bouvier, Alimentary Pharmacology & Therapeutics	2003	84
Endoscopic Retrograde Cholangiography Does Not Reliably Distinguish IgG4-Associated Cholangitis From Primary Sclerosing Cholangitis or Cholangiocarcinoma Evangelos Kalaitzakis, Michael J. Levy, Terumi Kamisawa, Clinical Gastroenterology and Hepatology Biliary TractBiliary CancerDistinguish Igg4-associated CholangitisGastroenterologyPathology	2011	80
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures N S Sandanayake, John Sinclair, Fausto Andreola, British Journal of Cancer	2011	80
Gray-scale ultrasonography and endoscopic pancreatography in pancreatic diagnosis. P B Cotton, W R Lees, A G Vallon, Radiology GastroenterologyDiagnosisPathologyRecurrent Acute PancreatitisSurgery	1980	68
Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer Michael H. Chapman, Neomal S. Sandanayake, Fausto Andreola, Journal of Clinical and Experimental Hepatology Prognostic BiomarkersMedicineBiliary CancerPathologyBiliary Tract Cancer	2011	55

Page 1